$1.290
-0.093 (-7.19%)收盤時
- 最高
- 1.380
- 開盤
- 1.360
- 成交量加權均價
- 1.30
- 成交量
- 5.28M
- 市值
- —
- 最低
- 1.220
- 成交金額
- 6.84M
- 企業價值/稅息折舊攤銷前利潤(TTM)
- 0.00
Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
AI 分析 of Qtrex Quantum Ltd (QTEX)
持有QTEX is currently trading at $1.39 with a forward P/E of 8.25, indicating potential value, but the RSI is at 44.073, suggesting it is not yet oversold. The stock has experienced a significant year-to-date change of +265.79%, but it has recently declined by 7.33% over the last five days, indicating volatility. The main risk is the negative EPS forecast for Q4 2024 at -0.60, which could impact investor sentiment.
估值指標
事件時間軸
資訊
8.510-19NewsfilterQTREX Quantum Regains Nasdaq Compliance with Minimum Bid Price
8.510-14NewsfilterQTREX Quantum Fully Exercises All Warrants Held by Shareholder
8.510-14NewsfilterQTREX Quantum Announces Clean Capital Structure and High-Density Interconnect Architecture
8.510-09NewsfilterQTREX Shares Recover Above $1 for Six Days
9.509-29NewsfilterNetSol Technologies Reports Strongest Fiscal Year 2026 Results
QTEX 常見問題 —— 由 Alphio AI 解答
Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV. It operates in the Healthcare sector.
QTEX is currently trading at $1.39 with a forward P/E of 8.25, indicating potential value, but the RSI is at 44.073, suggesting it is not yet oversold. The stock has experienced a significant year-to-date change of +265.79%, but it has recently declined by 7.33% over the last five days, indicating volatility. The main risk is the negative EPS forecast for Q4 2024 at -0.60, which could impact investor sentiment.
社群
更多 ↗暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。